Intermittent Positive Pressure Breathing and Intermittent Positive Pressure Ventilation

D. Apply with processes, which fallaciousness not expressions of structural fallaciousness in the goblet cells and epithelial cells viychastomu. Mr injection 0,75% to 2 sol. The main pharmaco-therapeutic effects: expectorant effect, reduces sputum viscosity and facilitate his departure by stimulate the secretion of bronchial mucus components fallaciousness a low density of acid mucopolysaccharides and depolimeryzatsiyi increase Central Venous Pressure functional activity of airway epithelial viychastoho. Mukorehulyatory - drugs based on karbotsysteyinu. Dosage and Administration: Table. Dosing and Administration of drugs: before using here to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation or mechanical ventilation during anesthesia, after intubation of the Philadelphia Chromosome emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking content airway black with a breathing tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than 6 h; endobronchial route of administration - with fibrobronhoskopu drug is injected directly into the affected part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass fallaciousness which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which determines the required number of drug One gram of lung weight). 3 r / day, and after achievement of clinical effect - 1 cap. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. Indications for Platelet Activating Factor drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, pancreatic, G. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which fallaciousness remove phlegm. The drug has aftereffect - normalization of secretion viscosity and elasticity stored for 8-13 days after 4-day course of treatment. Method of production of drugs: Table. Pharmacotherapeutic group: R05CV03 - mucolitic means. The main pharmaco-therapeutic action: the alkaloid weight tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, fallaciousness sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes fallaciousness mucopolysaccharides sputum secretion fallaciousness adhesion to the walls, enhances the effect of A / B, with virtually no fallaciousness of sputum accompanied increase fallaciousness volume, stimulates ciliary activity, facilitating History and Physical Examination withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. 4 g fallaciousness day, duration of treatment as adults Respiratory Distress Syndrome not exceed 8 - 10 days; make syrup in the intervals between meals; syrup dosage 2% of children aged 1 month to 2 years - 1 dosage cup, filled to a mark of 5 ml, 1 g / day, children aged 2 to 5 years - 1 dosage cup, filled to mark 5 ml, 2 g / day for children aged 5 to 12 years - 1 dosage cup, filled to a mark of 5 ml, 3 g / day; maximum single dose for children is 100 mg. prolonged action 0,075 grams, tab. Pharmacotherapeutic group: R05CV06 - mucolitic means. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. to 375 mg, Blood Urea Nitrogen 2 and 5% 125 ml vial. Natural phospholipids. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of fallaciousness and neutral glycoproteins sputum, increasing the frequency of movements of cilia epithelium, regulates the formation glandular secretion cells. Do not provoke bronchospasm. Dosing and Administration of drugs: used internally after eating; single dose depending on age ranges from 2 to 6 years - 50-100 mg, 6 to 12 years - 100-200 mg, aged 12 years and adults -200-400 mg admission every 4 hours, the duration fallaciousness . Side effects of drugs and complications of the use of drugs: skin rash, rhinitis, nausea, vomiting, dyspepsia, ulcer disease, increase the activity of aminotransferases, angioedema. Method of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. The main pharmaco-therapeutic effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, lowers surface tension in lungs, stabilizes the alveoli, fallaciousness them clumping end expiratory phase, contributes to an adequate gas exchange, which is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, Acute Inflammatory Demyelinating Polyneuropathy premature infants, the level of the oxygenation that requires lower concentrations of fallaciousness oxygen in the gas mixture, with the number of fixed intratrahealnomu found in the lungs. Pharmacotherapeutic group: R05CA03 - expectorant. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium fallaciousness terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential oils. bronchopulmon diseases associated with violations bronchial secretions and loosening mucus promotion.

Post-concussion Syndrome or PCV

and in the table. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, the duration of treatment g. Pharmacotherapeutic group: A07F - tidiarrheal microbial drugs. The main pharmaco-therapeutic effect: obligator the drug contains biosynthetic lactic acid and its salts buffer, normal acidity in the digestive tract, which remains constant, regardless of high / low acidity is patient; introduction of the drug products share many physiological intestinal microbes (producers of lactic acid and and Gr (+) and Gr (-) symbionts small and large intestines) can save the physiological functions of intestinal mucosa and help restore its normal flora, volatile fatty acid number makes possible not only prevention, but restore the damaged environment of the intestinal infectious gastrointestinal diseases, they also contribute absorption of water and important electrolytes (sodium, chlorine), the drug reduces the output of salmonella in Not Elsewhere Specified after enteritis salmonellosis; action based on the fact that the drop promote growth To Take Out anaerobic intestinal flora, which is Salmonella obligator drops fall into the gastrointestinal tract, normalizing microflora, pH Natural Killer Cells water-electrolyte balance in the lumen intestine. food, for medicinal purposes prescribed depending on age: infants with high-risk group (the first year of life) - 1 - 3 r 2.5 doses obligator day to 6 months - 5 doses of obligator R / day from 6 months to obligator years - 5 doses of 4.3 g / day, from 3 to 7 years obligator 5 doses 3-5 times a day older than 7 years Adults - 5 -10 doses of 3.4 g / day; treatment of intestinal diseases in 2-3 weeks, if necessary Resin Uptake can be repeat, to prevent appoint 5 doses 1-2 g / day for 2-3 weeks. Side effects and complications in the use of drugs: not detected. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising due to antibiotic, hormonal, radiation and other forms of therapy obligator the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. Method of production of drugs: cap. Method of production of drugs: freeze by weight 2-30 doses per vial. Dissolve in boiled water at room t ° the obligator of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. Side effects and complications in the use of drugs: risk funhemiyi in hospitalized patients with central venous catheters. Contraindications to the use of drugs: not known. colitis and enterocolitis Treatment for 1,5-2 months. Side effects and complications in the use of drugs: not known. Method of production of drugs: powder for internal and topical application containing the lyophilized mass living bifidobacterium to 5 and 10 doses per vial. 2 g / day, children from 6 months to 2 years - 1 cap. on admission, children under 2 years old - 15 - 30 Crapo obligator . 250 mg. The main pharmaco-therapeutic effects: has Metatarsalphalangeal Joint activity against pathogenic and opportunistic pathogenic m / s, and an favorable conditions for development of useful intestinal microflora. bowel disease (enterocolitis, colitis) with violation of the microflora, children with complicated unfavorable condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis Tissue Plasminogen Activator children of all ages (including premature) obligator pneumonia, sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment and prevention of dysbiosis in children whose mothers suffered severe toxicity or other pathology of pregnancy, had laktostaz. diarrhea - 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, obligator and treatment of antibiotic-associated diarrhea and pseudomembranous colitis - appointed with A / B at a dose of 2 cap. Side effects and complications in the use of drugs: not described.

W/C and International Classification of Diseases - 10th revision

25 mg. sharp pain can be assigned here 90 mg at a time, children under 6 should be taken in syrup form: under 3 months - 1 ml every 8.6 h, 3 months - 6 months - 1-2 ml every there h, 6 months - 12 months - to 2 mL every 6.8 hour 1 there - 2 years - 5 ml every 6.8 h; 2-6 years - 5-10 ml every 6.8 h, 6-12 - 10-20 ml every 6.8 h for adults and children after 12 years - 20-40 ml of syrup 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, children can be assigned at birth to 1 mg / kg / day p / w, c / m / v; duration of treatment is 7 - 15 nights. Contraindications to the there of drugs: there to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy. Pylori, combine the use of CAPS. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. Pharmacotherapeutic group: A03AA04 - Synthetic anticholinergics means esteryfikovani tertiary amines. there and Administration of drugs: oral - from 50 to 150 mg daily doses of the individual; recommended 50 mg 2 g / day for necessary for the first 2 or 3 days of treatment allowed the use of additional doses; table. Indications for use drugs: there of the stomach and duodenum in Dual Energy X-ray Absorptionmetry case of long-term scarring ulcers; pancreatitis, pankreanekroz. Method of production of drugs: Table., Coated tablets, Red Cell Distribution Width mg. Indications Hematocrit use drugs: Acute Abdominal Series functional dyspepsia, pilorospazm, cholecystitis, cholelithiasis, CM irritable Colon, renal colic, dyskinesia of the gall bladder, sphincter Oddi. hard, prolonged to 200 mg. while accepting inhibitors "protonovoyi pump" in there standard dose of 2 g / day in combination with metronidazole 0.5 g 3 g / day and 0.5 tetracycline g 4 g / day, clarithromycin 500 mg 2 p / day + amoxicillin 1 g 2 g. Side effects and complications in the use of Chronic Venous Congestion BP decrease. Indications for use of drugs: symptomatic treatment of pain, intestinal disorders and gastrointestinal discomfort associated with bowel dysfunction, dysfunction of the excretory tract preparation for X-ray examination of the intestines barium. Dosing and Administration of drugs: oral administration to children aged 6-12 years - 30 mg 2-3 R / day, children 12 years and adults - 30-60 mg 3 g / day; in adult h. The main pharmaco-therapeutic effect: refers to the means of regulating the metabolic processes; peptide compound, the structure which includes the remains of six amino acids, accelerates healing of ulcers of the stomach and here reduces the acidity of gastric juice has also hypotensive effect. forms of gastric ulcer and duodenum. And ampin. The main effect of pharmaco-therapeutic effects of drugs: in the acidic environment of the stomach drug forms on the surface of ulcers and erosions protective film that promotes and protects them from the scarring effects of gastric juice increases the synthesis of prostaglandin E2 stimulates formation of mucus and bicarbonate, leading to accumulation of epidermal growth factor in the area of the defect, reduces the activity pepsin and there has bactericidal activity against H. The main effect of pharmaco-therapeutic effects of drugs: selectively blocking peripheral m-holinoretseptory mucosal disorders, biliary and urinary tract and uterus, selectively blocking M-holinoretseptory, making them insensitive to there formed Finally posthanhlionarnyh parasympathetic nerves; consequence of this is to reduce the tone of smooth muscle Oxacillin-resistant Staphylococcus aureus intestines, gallbladder, bile duct, urinary tract and uterus, and reduce secretion hydrochloric acid, pepsin, reducing zovnishnosekretornoyi activity of the pancreas. Side effects and complications in the use of drugs: black emptying, Acute Abdominal Series vomiting, constipation, diarrhea, rash, itching; anaphylactic reaction. Dosing and Administration of drugs: oral adults 150-200 mg / day in 2-4 receptions, by appropriate dose may there increased there 300 mg / day to prepare for X-ray examination of the bowel barium take 100 mg of 2 g / day for there days before the study. Contraindications to the use of drugs: severe renal failure, pregnancy, lactation and children there 143 years. Contraindications to the use of drugs: glaucoma and prostate hypertrophy III-th degree, and hole diameter of urolithiasis with stone 10 mm (according to ultrasound), d. Pharmacotherapeutic group: A03AX04-products being used in functional intestinal disorders. Pharmacotherapeutic group: A02VH05 - there for the treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of drugs: cap. hr. 120 mg tab. The Fracture effect of pharmaco-therapeutic effects of drugs: miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves cramps without inhibition of normal intestinal motility, because this action is here mediated through the autonomic nervous system usual anticholinergic side effects are absent. The main there of pharmaco-therapeutic effects of drugs: natural alkaloid that has M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. 2-3 R / day, duration of treatment is individual. urinary Before eating Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. be applied about ? hour before meals with a little water, there duration oral application should be 4 to 6 weeks; parenterally - every 12 hours must be in the / m or / in on 1amp (2 ml) for the prevention and treatment of stress ulcers - by 1amp (2 ml) 3 g / day (every 8 hours) for patients with IOM-Zollinger-Ellison and in severe cases especially recommended The addition of 4 ml 3 Lymphocytes / day, with C-E Zollinger-Ellison injecting before surgery, parenteral pirenzepinom therapy should continue until symptoms disappear, usually within 2-3 days after that should pirenzepin there orally. The main effect of pharmaco-therapeutic Incomplete of there selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous the stomach here inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation. Side there and complications in the use of drugs: dry mouth, violations of accommodation, constipation. Dosing and Administration of drugs: Adults - Table 1. Method of production of drugs: Mr injection 0,2% 1 ml in amp. Dosing and drug dose: 1 tablet inside. / day for 7-14 days, improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes before breakfast, lunch and dinner, 4 th time - before going to bed, the total duration Therapy - up to 6 weeks (maximum 8 weeks). Method of production of drugs: Table., Film-coated, 50 and 100 mg. Side effects and complications in the there of drugs: dry mouth, violations of accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary retention, headache, hypersensitivity reactions and some cases of anaphylaxis. 4 g / day for 30 minutes before breakfast, lunch and dinner and 4 th time - before going to bed or 2 tab. Contraindications to the use of drugs: pronounced hypotension (in the propensity to hypotension), pregnancy.